Home › NDC Lookup › RxCUI directory › RxCUI 1665102

Cefoxitin 1000 MG Injection — RxCUI 1665102

Name: Cefoxitin 1000 MG Injection (RxCUI 1665102)
Creator: Brian Staiger, PharmD

RxNorm drug concept · Semantic clinical drug

RxCUI 1665102 Semantic clinical drug · SCD ● Current RxNorm concept 14 FDA products 14 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by Dr. Brian Staiger, PharmD

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI1665102

Official nameCefoxitin 1000 MG Injection

Concept typeSemantic clinical drug (SCD)

RxNorm statusCurrent RxNorm concept

Also known ascefoxitin 1 GM Injection; cefoxitin (as cefoxitin sodium) 1000 MG Injection

FDA products mapped14

Package NDCs mapped14

Reported Medicaid activity (SDUD)4,215 prescriptions · 26 state & territory Medicaid programs · latest period Q4 2025

RxNorm release07/06/2026

Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Cefoxitin Injection: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist

Cefoxitin is used for serious bacterial infections in several parts of the body — including the lungs, urinary tract, abdomen, female reproductive system, bloodstream, bones and jo...
What kinds of infections does cefoxitin treat?
Cefoxitin is given through an IV — directly into a vein — by a nurse or other healthcare professional. It's not a pill or something you take at home on your own. You'll receive it...
How will I receive this medication? Do I take it at home?

📖 Read our full Cefoxitin Injection guide →

🕸️ Concept Web — How Cefoxitin 1000 MG Injection Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.

This page's concept Cefoxitin 1000 MG Injection RxCUI 1665102 Semantic clinical drug · SCD

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

Ingredients 1

The active substance itself — no strength, form, or brand attached yet.
- Cefoxitin 2189 IN
Dose forms 4

The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
- Cefoxitin Injection 1665101 SCDF
- Cefoxitin Injectable Product 1152105 SCDG
- Injection 1649574 DF
- Injectable Product 1151126 DFG
Clinical & branded drugs 1

Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
- Cefoxitin 1000 MG 1665100 SCDC

Showing up to 8 concepts per family — 6 of 6 stored related concepts drawn.

These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

Cefoxitin 1000 MG SCDC · 1665100
Cefoxitin Injection SCDF · 1665101
Cefoxitin Injectable Product SCDG · 1152105

📦 FDA Products & Package NDCs

14 products · 14 package NDCs

14 package NDCs map to RxCUI 1665102 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.

Package NDC	Package	Brand / generic name	Labeler	Marketing start
00143-9877-25	25 VIAL in 1 CARTON (0143-9877-25) / 1 INJECTION, POWDER, F...	Cefoxitin	Hikma Pharmaceuticals USA Inc.	2010-03-12
00143-9878-25	25 VIAL in 1 CARTON (0143-9878-25) / 1 INJECTION, POWDER, F...	Cefoxitin	Hikma Pharmaceuticals USA Inc.	2010-03-12
00264-3123-11	24 CONTAINER in 1 CASE (0264-3123-11) / 50 mL in 1 CONTAINE...	Cefoxitin and Dextrose	B. Braun Medical Inc.	2006-03-10
00264-3125-11	24 CONTAINER in 1 CASE (0264-3125-11) / 50 mL in 1 CONTAINE...	Cefoxitin and Dextrose	B. Braun Medical Inc.	2006-03-10
25021-0109-10	10 VIAL in 1 CARTON (25021-109-10) / 1 INJECTION, POWDER, F...	Cefoxitin	Sagent Pharmaceuticals	2009-11-05
25021-0110-20	10 VIAL in 1 CARTON (25021-110-20) / 1 INJECTION, POWDER, F...	Cefoxitin	Sagent Pharmaceuticals	2009-11-05
44567-0245-25	25 VIAL in 1 CARTON (44567-245-25) / 1 INJECTION, POWDER, F...	Cefoxitin	WG Critical Care, LLC	2015-02-18
44567-0245-85	25 VIAL in 1 CARTON (44567-245-85) / 1 INJECTION, POWDER, F...	Cefoxitin	WG Critical Care, LLC	2017-07-10
44567-0246-25	25 VIAL in 1 CARTON (44567-246-25) / 1 INJECTION, POWDER, F...	Cefoxitin	WG Critical Care, LLC	2015-02-18
44567-0246-85	25 VIAL in 1 CARTON (44567-246-85) / 1 INJECTION, POWDER, F...	Cefoxitin	WG Critical Care, LLC	2017-07-10
63323-0341-25	25 VIAL in 1 CARTON (63323-341-25) / 1 POWDER, FOR SOLUTION...	Cefoxitin	Fresenius Kabi USA, LLC	2011-07-06
63323-0341-29	25 VIAL in 1 CARTON (63323-341-29) / 1 POWDER, FOR SOLUTION...	Cefoxitin	Fresenius Kabi USA, LLC	2011-07-06
63323-0342-25	25 VIAL in 1 CARTON (63323-342-25) / 1 POWDER, FOR SOLUTION...	Cefoxitin	Fresenius Kabi USA, LLC	2011-07-06
63323-0342-29	25 VIAL in 1 CARTON (63323-342-29) / 1 POWDER, FOR SOLUTION...	Cefoxitin	Fresenius Kabi USA, LLC	2011-07-06

Observed labelers: Fresenius Kabi USA, LLC (4) · WG Critical Care, LLC (4) · B. Braun Medical Inc. (2) · Hikma Pharmaceuticals USA Inc. (2) · Sagent Pharmaceuticals (2) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🧾 Billing Codes (HCPCS)

Medical billing codes (HCPCS "J-codes") that connect to this concept's packages — used mostly when a clinic or hospital bills for a drug it administers. Each code links to its full billing page.

Code	Descriptor	Mapped packages	Sources
J0694	Cefoxitin sodium injection	12	CMS

⚠ A crosswalk is not coverage: an NDC↔HCPCS mapping does not guarantee any payer covers or pays the code. Always verify the current payer policy before billing.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7

openFDA export observedJul 14, 2026

RxNorm release07/06/2026

Methodology2026-07-full-catalog-v1

A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.

This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.